Cargando…

Methods for improved hemorrhage control

Trauma is the leading cause of death from age 1 to 34 years and is the fifth leading cause of death overall in the USA, with uncontrolled hemorrhage being the leading cause of potentially preventable death. Improving our ability to control hemorrhage may represent the next major hurdle in reducing t...

Descripción completa

Detalles Bibliográficos
Autor principal: Holcomb, John B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226142/
https://www.ncbi.nlm.nih.gov/pubmed/15196327
http://dx.doi.org/10.1186/cc2407
_version_ 1782217567933300736
author Holcomb, John B
author_facet Holcomb, John B
author_sort Holcomb, John B
collection PubMed
description Trauma is the leading cause of death from age 1 to 34 years and is the fifth leading cause of death overall in the USA, with uncontrolled hemorrhage being the leading cause of potentially preventable death. Improving our ability to control hemorrhage may represent the next major hurdle in reducing trauma mortality. New techniques, devices, and drugs for hemorrhage control are being developed and applied across the continuum of trauma care: prehospital, emergency room, and operative and postoperative critical care. This brief review focuses on drugs directed at life-threatening hemorrhage. The most important of these new drugs are injectable hemostatics, fibrin foams, and dressings. The available animal studies are encouraging and human studies are required.
format Online
Article
Text
id pubmed-3226142
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32261422011-11-30 Methods for improved hemorrhage control Holcomb, John B Crit Care Review Trauma is the leading cause of death from age 1 to 34 years and is the fifth leading cause of death overall in the USA, with uncontrolled hemorrhage being the leading cause of potentially preventable death. Improving our ability to control hemorrhage may represent the next major hurdle in reducing trauma mortality. New techniques, devices, and drugs for hemorrhage control are being developed and applied across the continuum of trauma care: prehospital, emergency room, and operative and postoperative critical care. This brief review focuses on drugs directed at life-threatening hemorrhage. The most important of these new drugs are injectable hemostatics, fibrin foams, and dressings. The available animal studies are encouraging and human studies are required. BioMed Central 2004 2004-06-14 /pmc/articles/PMC3226142/ /pubmed/15196327 http://dx.doi.org/10.1186/cc2407 Text en
spellingShingle Review
Holcomb, John B
Methods for improved hemorrhage control
title Methods for improved hemorrhage control
title_full Methods for improved hemorrhage control
title_fullStr Methods for improved hemorrhage control
title_full_unstemmed Methods for improved hemorrhage control
title_short Methods for improved hemorrhage control
title_sort methods for improved hemorrhage control
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226142/
https://www.ncbi.nlm.nih.gov/pubmed/15196327
http://dx.doi.org/10.1186/cc2407
work_keys_str_mv AT holcombjohnb methodsforimprovedhemorrhagecontrol